Daniel is a Stanford & Harvard trained physician, scientist, entrepreneur and innovator who speaks on how rapidly developing technologies are and will impact the future of health and medicine. Daniel chairs the XPRIZE Pandemic Alliance Task Force.

Why Daniel Kraft?
• From the perspective of a leading physician, scientist, inventor and innovator this presentation examines rapidly emerging, game changing and convergent technology trends and how they are and will be leveraged to change the face of healthcare and the practice of medicine in the next decade.

Daniel is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has chaired the Medicine for Singularity University since its inception in 2008, and is founder and chair of Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare. Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children's Hospital, and fellowships in hematology, oncology and bone marrow transplantation at Stanford. He is the Chair of the XPRIZE Pandemic Alliance Task Force.

He is often called upon to speak to the future of health, medicine and technology and has given 4 TED and 2 TEDMED Talks.

He has multiple scientific publications and medical device, immunology and stem cell related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at University of California San Francisco.

Daniel is a member of the Kaufman Fellows Society (Class 13) and member of the Inaugural (2015) class of the Aspen Institute Health Innovators Fellowship.

Daniel's academic research has focused on: stem cell biology and regenerative medicine, stem cell-derived immunotherapies for cancer, bioengineering human T-cell differentiation, and humanized animal models. Clinical work focuses on: bone marrow / hematopoietic stem cell transplantation for malignant and non-malignant diseases in adults and children, medical devices to enable stem cell based regenerative medicine, including marrow derived stem cell harvesting, processing and delivery. He also implemented the first text-paging system at Stanford Hospital.

He is heavily involved in digital health, founded Digital.Health, and is on the board of Healthy.io and advises several digital health related startups. Daniel recently founded IntelliMedicine, focused on personalized, data driven, precision medicine. He is also the inventor of the MarrowMiner, an FDA approved device for the minimally invasive harvest of bone marrow and founded RegenMed Systems, a company developing technologies to enable adult stem cell based regenerative therapies.

• Dr. Kraft was named one of The Top Ten Internet-Smart Doctors in the World by Internet Medicine.com
• Daniel Kraft, MD is one of the 40 Smartest People in Healthcare by Becker’s Hospital Review


SPEAKER | SIGNATURE KEYNOTE [in-person and virtual keynotes available]:

Daniel has been asked to keynote many programs around the world on how rapidly developing technologies are and will impact the future of healthcare and biomedicine.

• THE FUTURE OF HEALTH & MEDICINE: WHERE CAN TECHNOLOGY TAKE US?
From the perspective of a leading physician, scientist and innovator this presentation examines rapidly emerging, game changing and convergent technology trends and how they are and will be leveraged to change the face of healthcare and the practice of medicine in the next decade.
A deep dive into where emergent fields such as low cost personal genomics, the digitization of health records, crowd sourced data, molecular imaging, wearable devices & mobile health, synthetic biology, systems medicine, robotics, artificial intelligence, nanotechnology, 3D printing and regenerative medicine are transforming healthcare, and have the potential to enable clinicians, empower patients, and deliver better care and outcomes at lower cost.